FGD5 and hepatocellular carcinoma: The current findings support that SNHG1, SNHG12, LINC00511, HCG18, FGD5-AS1, CERS6-AS1, NUTM2A-AS1, SNHG16, and ASB16-AS1, upregulated and linked to poor prognosis in hepatocellular carcinoma, might be the most potential lncRNAs that bind to previous identified miRNAs, hsa-mir-195-5p, hsa-mir-497-5p, and hsa-mir-122-5p.